<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schafer N</submitter><funding>European Union’s Seventh Framework Programme</funding><funding>Danish Council for independent research</funding><funding>German Research Foundation</funding><funding>King Saud University, Saud Arabia</funding><funding>Russian Academic Excellence Project</funding><funding>Horizon 2020 Research and Innovation Programme</funding><funding>King Saud University, Saudi Arabia</funding><pagination>e0205109</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6171906</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(10)</volume><pubmed_abstract>Sodium-glucose transporters (SGLT) belong to the solute carrier 5 family, which is characterized by sodium dependent transport of sugars and other solutes. In contrast, the human SGLT3 (hSGLT3) isoform, encoded by SLC5A4, acts as a glucose sensor that does not transport sugar but induces membrane depolarization by Na+ currents upon ligand binding. Whole-exome sequencing (WES) of several extended pedigrees with high density of attention-deficit/hyperactivity disorder (ADHD) identified a triplet ATG deletion in SLC5A4 leading to a single amino acid loss (ΔM500) in the hSGLT3 protein imperfectly co-segregating with the clinical phenotype of ADHD. Since mutations in homologous domains of hSGLT1 and hSGLT2 were found to affect intestinal and renal function, respectively, we analyzed the functio</pubmed_abstract><journal>PloS one</journal><pubmed_title>Functional analysis of a triplet deletion in the gene encoding the sodium glucose transporter 3, a potential risk factor for ADHD.</pubmed_title><pmcid>PMC6171906</pmcid><funding_grant_id>DFF-6108-00122</funding_grant_id><funding_grant_id>5-100</funding_grant_id><funding_grant_id>728018 (Eat2beNICE</funding_grant_id><funding_grant_id>SFB TRR58-A05</funding_grant_id><funding_grant_id>FP7/2007–2013/No. 602805</funding_grant_id><pubmed_authors>Friedrich M</pubmed_authors><pubmed_authors>Kollert S</pubmed_authors><pubmed_authors>Doring F</pubmed_authors><pubmed_authors>Schafer N</pubmed_authors><pubmed_authors>Lesch KP</pubmed_authors><pubmed_authors>Koepsell H</pubmed_authors><pubmed_authors>Wischmeyer E</pubmed_authors><pubmed_authors>Jorgensen ME</pubmed_authors><pubmed_authors>Geiger D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Functional analysis of a triplet deletion in the gene encoding the sodium glucose transporter 3, a potential risk factor for ADHD.</name><description>Sodium-glucose transporters (SGLT) belong to the solute carrier 5 family, which is characterized by sodium dependent transport of sugars and other solutes. In contrast, the human SGLT3 (hSGLT3) isoform, encoded by SLC5A4, acts as a glucose sensor that does not transport sugar but induces membrane depolarization by Na+ currents upon ligand binding. Whole-exome sequencing (WES) of several extended pedigrees with high density of attention-deficit/hyperactivity disorder (ADHD) identified a triplet ATG deletion in SLC5A4 leading to a single amino acid loss (ΔM500) in the hSGLT3 protein imperfectly co-segregating with the clinical phenotype of ADHD. Since mutations in homologous domains of hSGLT1 and hSGLT2 were found to affect intestinal and renal function, respectively, we analyzed the functio</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018</publication><modification>2026-04-30T03:21:58.293Z</modification><creation>2019-03-27T00:03:32Z</creation></dates><accession>S-EPMC6171906</accession><cross_references><pubmed>30286162</pubmed><doi>10.1371/journal.pone.0205109</doi></cross_references></HashMap>